As doctors and clinicians continue to look for breakthroughs in treatments for COVID-19, could the anti-malarial drug, hydroxychloroquine, prove to be a possible prophylactic? Newt talks with Dr. David Pearce of Sanford Health. Sanford Health is conducting the first controlled hydroxychloroquine clinical trial in the United States.][vc
GUEST – DR. DAVID PEARCE
ARTICLES
FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems – FDA
Emergency Use Authorization for Use of Chloroquine Phosphate or Hydroxychloroquine Sulfate Supplied From the Strategic National Stockpile for Treatment of 2019 Coronavirus Disease – FDA
